Evidence map›Paper›PMID 33556313›Full record

ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2021

2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).

Fred Saad, Armen Aprikian, Antonio Finelli, Neil E Fleshner, Martin Gleave, Anil Kapoor, Tamim Niazi, Scott A North, Frederic Pouliot, Ricardo A Rendon and 6 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Gender bias in shared decision-making among cancer care guidelines: A systematic review.Health expectations : an international journal of public participation in health care and health policy · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Genetic testing practices among specialist physicians who treat prostate cancer A Canadian, cross-sectional survey.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2023
    Article
  7. BeTTer Outcomes Workgroup Health Quality Initiative to optimize bone health for prostate cancer patients in the British Columbia Cancer System.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. UPDATE - Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022
    Article
  12. Review
  13. Observational
  14. Review
  15. Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Fred SaadCentre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Armen AprikianMcGill University Health Center, Montreal, QC, Canada.
Antonio FinelliDivision of Urology, University of Toronto, Toronto, ON, Canada.
Neil E FleshnerDivision of Urology, University of Toronto, Toronto, ON, Canada.
Martin GleaveDepartment of Urological Sciences, University of British Columbia, Vancouver, BC, Canada.
Anil KapoorDepartment of Surgery (Urology) and Oncology, McMaster University, Hamilton, ON, Canada.
Tamim NiaziJewish General Hospital, Montreal, QC, Canada.
Scott A NorthDepartment of Medical Oncology, University of Alberta, Edmonton, AB, Canada.
Frederic PouliotCHU de Quebec, Université Laval, Quebec City, QC, Canada.
Ricardo A RendonDepartment of Urology, Dalhousie University, Halifax, NS, Canada.
Bobby ShayeganDepartment of Surgery (Urology) and Oncology, McMaster University, Hamilton, ON, Canada.
Srikala S SridharDivision of Medical Oncology, University of Toronto, Toronto, ON, Canada.
Alan SoDepartment of Urological Sciences, University of British Columbia, Vancouver, BC, Canada.
Nawaid UsmaniDepartment of Oncology, Division of Radiation Oncology, University of Alberta, Edmonton, AB, Canada.
Eric VigneaultDepartment of Radiation Oncology, CHU de Quebec, Université Laval, Quebec City, QC, Canada.
Kim N ChiBC Cancer Agency, Vancouver, BC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33556313
PMCPMC7864710

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.